Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The Food and Drug Administration said on Friday that the shortage of semaglutide injection products, such as Novo Nordisk's Wegovy, has been resolved. FDA's update led to renewed uncertainty for a ...

The Food and Drug Administration announced Friday it had officially declared an end to the nationwide shortage of Ozempic and Wegovy, medications used for diabetes and weight loss.The agency first ...

The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive changes.

Experts say it’s not yet clear how safe these drugs are for people who don’t need to lose weight ... the drugs would be for a ...

Florida has sunny skies, tropical weather and alluring beaches that entice visitors with our lively culture. Orlando MCO is ...

To lose weight, you need to be in a calorie deficit. However, it's not as simple as consuming fewer calories. Depending on your physical activity, age, calories burned and more factors ...

While Sanheim did pick up an assist as part of the loss to the Capitals, he also committed a team-high four giveaways. The Philadelphia Flyers will look to bounce back when they host the ...

The Philadelphia Flyers battled until the final horn in a narrow 4-3 loss to the Washington Capitals. While the result stung, the effort was admirable against one of the league’s most ...

This led to the development of the wave of obesity-fighting drugs that are hotly discussed today: semaglutide, known better by its brand names Wegovy (for weight loss) or Ozempic (for Type 2 ...